GSK · 10000+ people · Public
Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation
- Belgium-Wavre
- Hybrid
- €119,250 – €198,750 pa
- Director
Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis to small molecules, biologics and antibody drug conjugates. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.
NONMEM · R